<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>106</startPage>
              <endPage>113</endPage>
              <doi>10.26663/cts.2019.00121</doi>
              <publisherRecordId>87</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Starting experience in robotic thoracic surgery</title>
                <authors>
                              <author>
                                <name>Murat  Akkuş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Saglik Bilimleri University, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;The robotic assisted thoracoscopic surgery (RATS) spreads rapidly across the whole
world. In this paper, the objective was to present the training experience on RATS in our clinic along
with the literature.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Sixty-three consecutive patients, who had undergone RATS between
February 2014 and December 2018, were included in this retrospective non-randomized study. The
training period was designed as three phases. Twelve patients with solid and cystic mass lesions in the
mediastinum and chest wall were included in group Phase 1. The group Phase 2 consisted of 16 patients
who had thymoma and benign pulmonary mass lesions, and 35 consecutive patients were enrolled into
group Phase 3 group who had undergone lobectomy.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The patients in all groups were compared in respect of the preoperative, perioperative and
postoperative results. The docking time was significantly shorter in Phase 3 patients compared to the
groups Phase 1 and 2 (p &lt; 0.05). In the lobectomy group (Phase 3), as the console time and operation
time was significantly shorter after the 20th patient than the prior patients, first 20 patients were accepted
as the learning curve (p &lt; 0.05). In the lobectomy group, in three patients the operation was converted
to open surgery during the perioperative period (4.7%). No mortality was observed during the 30-day
follow-up. One patient died in the 6th month of the long-term follow-up. The mean follow-up duration
was 28.4 months.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; RATS is a safe, feasible, and minimally invasive method, which has low complication
rates with a satisfying and short learning curve.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=87</fullTextUrl>
              <keywords><keyword>robot-assisted thoracoscopic surgery</keyword><keyword>robotic lobectomy</keyword><keyword>minimally invasive thoracic surgery</keyword><keyword>robotic surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>114</startPage>
              <endPage>119</endPage>
              <doi>10.26663/cts.2019.00122</doi>
              <publisherRecordId>88</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Evaluation of the effect of video-assisted thoracoscopic surgery on early postoperative pain and quality of life</title>
                <authors>
                              <author>
                                <name>Levent  Cansever</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Celal Bugra Sezen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Ali Bedirhan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Health Application and Research Center, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Video-assisted thoracoscopic surgery (VATS) is more advantageous than open surgery. In
particular, VATS is superior in terms of pain, physical functioning, and overall patient satisfaction. The
aim of this study was to evaluate factors affecting early postoperative pain and quality of life in patients
who underwent VATS for benign or malignant disease.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Seventy-seven patients who underwent VATS in our hospital between March
1 and June 30, 2018 were evaluated retrospectively. Postoperative pain was assessed at 2, 6, and 24
hours postoperatively using Visual Analogue Scale (VAS). The short-form 36 (SF-36) quality of life
questionnaire was used to assess early quality of life.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Of the 74 patients in the study, 50 were male (67.6%) and 24 were female (32.4%). Mean VAS
score was 6.84 ± 1.63 at postoperative hour 2, 4.19 ± 1.36 at postoperative hour 6, and 2.58 ± 1.20 at
postoperative day 1. Geriatric patients had significantly higher VAS pain scores at postoperative hour
6 and day 1 (p = 0.011, p = 0.013). Patients with benign disease had significantly higher quality of life
compared to patients with malignancy (p &lt; 0.001). The presence of complications and advanced age
were associated with lower postoperative quality of life.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Although VATS patients have less severe pain and better quality of life in the early
postoperative period, patients with malignancy had worse physical, psychological, and emotional
state. In addition, geriatric patients and patients with early postoperative complications showed larger
decreases in early postoperative quality of life.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=88</fullTextUrl>
              <keywords><keyword>quality of life</keyword><keyword>video-assisted thoracoscopic surgery</keyword><keyword>tumor</keyword><keyword>lung cancer</keyword><keyword>treatment</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>120</startPage>
              <endPage>125</endPage>
              <doi>10.26663/cts.2019.00123</doi>
              <publisherRecordId>89</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Sustained preservation of pulmonary function after pleurectomy/ decortication: should it be the main reason to perform surgery in malignant pleural mesothelioma patients?</title>
                <authors>
                              <author>
                                <name>Simge  Ozer</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Serdar  Ince</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tugce Sevval Koyi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Aslihan  Cikmazkara</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Sevim Gulsen Ozeren</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Zeynep  Bilgi</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Hasan Fevzi Batirel</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Marmara University, School of Medicine, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Medeniyet University, School of Medicine, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Pleurectomy/decortication for malignant pleural mesothelioma is performed to improve
survival and pulmonary function. Our aim was to analyze pulmonary function outcomes following
pleurectomy/decortication.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;95 patients underwent pleurectomy/decortication for mesothelioma between
years 2005-2016. 30 patients were alive at the time of analysis. Three patients were not fit to perform
spirometry and three patients were living in rural areas. In 24 patients, spirometry was performed and
compared with preoperative values. Demographic data, side, surgical technique, histology, recurrence,
FEV1 (% and L), FVC (% and L), change in FEV1 and FVC were recorded and analyzed. A control
group (n = 9) was formed with lung cancer patients who underwent lower lobectomy.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Average age was 56 ± 10 years (26-75). 13 extended and 11 partial pleurectomy/decortications
were performed. Average hospital stay was 6.9 ± 3.4 days. 21 patients had epithelioid and 13 had T3-4
tumors. 23 patients had adjuvant chemotherapy, while 7 had adjuvant high dose radiation. Median
survival was 31 months (6.4 - 83). Average preoperative and recent FEV1 (L) were 2.18 ± 0.82 and 1.84
± 0.61 respectively (p = 0.004). The values were slightly higher for lower lobectomy patients. Average
percentage change in FEV1 was -11.5 ± 23 which was very similar with control group (-12.4 ± 15). In
6 MPM patients, recent FEV1 (L) was higher than preoperative.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Pleurectomy/decortication results in stable or improved pulmonary function in 40% of
the patients independent of survival. The change in FEV1 is identical with lower lobectomy patients.
Pleurectomy/decortication should be the preferred technique in resectable mesothelioma patients.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=89</fullTextUrl>
              <keywords><keyword>malignant pleural mesothelioma</keyword><keyword>pulmonary function</keyword><keyword>pleurectomy/decortication</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>126</startPage>
              <endPage>130</endPage>
              <doi>10.26663/cts.2019.00124</doi>
              <publisherRecordId>90</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">The role of bronchoalveolar pattern of the former classification in the 8th edition of iaslc-tnm classification</title>
                <authors>
                              <author>
                                <name>Demet  Yaldız</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Arkın  Acar</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Zekiye  Aydoğdu</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Şeyda Örs Kaya</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Sadık Yaldız</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Manisa Celal Bayar University, School of Medicine, Manisa, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Dr. Suat Seren Chest Diseases and Thoracic Surgery Training Hospital, İzmir, Turkey</affiliationName><affiliationName affiliationId="3">Deparment of Pathology, Dr. Suat Seren Chest Diseases and Thoracic Surgery Training Hospital, İzmir, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Until the reclassification by the International Association for the Study of Lung Cancer,
the term bronchoalveolar carcinoma (BAC) has been used for many years. Accordingly, the terms BAC
and mixed adenocarcinoma were replaced by the terms such as adenocarcinoma in situ, minimally
invasive adenocarcinoma, lepidic dominant type adenocarcinoma, mucinous minimally invasive
adenocarcinoma, and mucinous invasive adenocarcinoma. The aim of this study was to retrospectively
evaluate the cases diagnosed as BAC and mixed type adenocarcinoma operated in our clinic and to
compare the clinical and survival characteristics of these cases according to the new classification.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;37 patients who were operated in our clinic between January 2005 and
December 2014 and diagnosed as BAC and mixed adenocarcinoma containing BAC components were
included in the study. Pathologic slides were re-reviewed by the pathologists of our hospital and reclassified
according to the predominant histologic subtype. In addition to the predominant cell type, the
ratio of other cell types were also specified in 5% ratio slices.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The histopathological diagnoses of 37 formerly BAC patients, 14 of whom were mixed
type, were changed as 33 lepidic, two mucinous, one adenocarcinoma in situ and one micro-invasive
adenocarcinoma. The 5-year survival rate for lepidic predominant histological subtype was 70.3, while
it was 50% (p = 0.533) for the two mucinous cases.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;The predominant cell type distribution used in the new classification of IASLC is more
effective in determining survival and is more suitable for use in treatment and follow-up programs.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=90</fullTextUrl>
              <keywords><keyword>lung cancer</keyword><keyword>adenocarcinoma</keyword><keyword>bronchoalveolar carcinoma</keyword><keyword>classification</keyword><keyword>staging</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>131</startPage>
              <endPage>135</endPage>
              <doi>10.26663/cts.2019.00125</doi>
              <publisherRecordId>91</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Rediscovering the legendary treatment of prolonged air leak: therapeutic pneuomoperitoneum</title>
                <authors>
                              <author>
                                <name>Şevki Mustafa Demiröz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Göktürk  Fındık</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>İlteriş  Türk</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Koray  Aydoğdu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Funda  İncekara</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Sadi  Kaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Therapeutic pneumoperitoneum was first described for overcoming pulmonary tuberculosis
in the end of 19th century. However, in time, another indication “prolonged air leak” (PAL) after major
lung resections, lung volume reduction surgery and decortication operations have come on the scene and
this legendary treatment have took place again. Despite the developing technology, medical devices and
tools thoracic surgeons still sometimes need to use this treatment to cope with PAL.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Twelve patients underwent pulmonary operations were included. Nine of the
patients had PAL and three had massive air leak with subcutaneous emphysema in early postoperative
period. On mean postoperative 8th day (1-15), a one session pneumoperitoneum was applied. In order to
fulfill the vascular bed to prevent from air embolism, all of the patients received 500-1500cc of intravenous
saline so that the venous pressure is between 7 and 12.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; All 12 patients developed no sequel or chronic complications due to the intervention. Mean hospital
stay after the intervention was 8.1 days (2-12), mean chest tube removal time after pneumoperitoneum
was 16 days (2-48). Six of the patients were discharged with a complete success (without a chest tube),
five patients were discharged with a Heimlich valve and one with passive drainage catheter, but the latter
patients were also fully recovered in following days.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; In this report, we present 12 cases treated successfully with therapeutic pneumoperitoneum
without any severe complications. The unique side of our technique is we used only single application
without any need of extra instruments.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=91</fullTextUrl>
              <keywords><keyword>prolonged air leak</keyword><keyword>pneumoperitoneum</keyword><keyword>lung resection</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>136</startPage>
              <endPage>139</endPage>
              <doi>10.26663/cts.2019.00126</doi>
              <publisherRecordId>92</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">A rare cause of chest pain: pleuropulmonary solitary fibrous tumor</title>
                <authors>
                              <author>
                                <name>Raúl Gonzalez Luna</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Gerardo Rea Mendoza</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Christian Ramirez Sanchez</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Organismo Público Descentralizado de Hospitales Civiles de Guadalajara, Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico</affiliationName></affiliationsList><abstract language="eng">A 45-year-old female patient is referred to our service for presenting seven months with left chest pain
accompanied by dyspnea. At the chest tomography, a low-density mass with the presence of multiple
vascularized septa, without evidence of tumor extension, without mediastinum nodes growth, neither
metastatic lesions. The patient was operated with posterolateral thoracotomy. In the exploration, a 10x8x6
cm spherical mass was found which was solid, mobile, with pulmonary apical parenchyma peduncle, and
it was totally excised. The postoperative pathology of the patient was reported as a pleuropulmonary
solitary fibrous tumor. The management of this case took guidance from the Perrot’s recommendations,
surgical resection is the mainstay treatment.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=92</fullTextUrl>
              <keywords><keyword>pleuropulmonary solitary fibrous tumor</keyword><keyword>solitary fibrous tumor of the pleura</keyword><keyword>surgical resection</keyword><keyword>stratification models</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>140</startPage>
              <endPage>142</endPage>
              <doi>10.26663/cts.2019.00127</doi>
              <publisherRecordId>93</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">The treatment of foreign body reaction and inflammation caused by prosthetic material with surgery and negative pressure wound therapy</title>
                <authors>
                              <author>
                                <name>Yunus  Aksoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Necati  Çıtak</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Özgür  İşgörücü</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Çiğdem  Obuz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Adnan  Sayar</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Chest Diseases and Thoracic Surgery Health Research and Application Center, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Istanbul Bakirkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery, Memorial Bahçelievler Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">Foreign body reaction and deep wound infection (DWI) following sternal resection and reconstruction
represent a serious problem. In recent years, negative pressure wound therapy (NPWT) have been used
in clinical practice for treatment of DWIs. However, publications regarding the use of NPWT for the
prosthetic material-related inflammation and DWI are yet quite rare. We present a very rare case, which is
characterized with foreign body reaction and DWI after sternal reconstruction for a giant chondrosarcoma
with the treatment of surgical debridement and NPWT.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=93</fullTextUrl>
              <keywords><keyword>chest wall reconstruction</keyword><keyword>sternal wound infection</keyword><keyword>foreign body reaction</keyword><keyword>surgery</keyword><keyword>negative pressure wound therapy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>143</startPage>
              <endPage>145</endPage>
              <doi>10.26663/cts.2019.00128</doi>
              <publisherRecordId>94</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Chest wall hydatid cyst: a case report</title>
                <authors>
                              <author>
                                <name>Egemen  Döner</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muammer Cumhur Sivrikoz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Erhan  Durceylan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Eskişehir Osmangazi University, Faculty of Medicine, Eskişehir, Turkey</affiliationName></affiliationsList><abstract language="eng">Hydatid cyst is a parasitic disease caused by Echinococcus cestode. Hydatid cyst is an important risk factor
in rural areas especially in Mediterranean countries, Middle East and Australia. The disease is most common
in the liver and then in the lungs and it is very rare to be seen primarily in the chest wall. We present a 31
years-old female patient with primary chest wall hydatid cyst and discuss the surgical treatment.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=94</fullTextUrl>
              <keywords><keyword>albendazole</keyword><keyword>chest wall</keyword><keyword>hydatid cyst</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>146</startPage>
              <endPage>149</endPage>
              <doi>10.26663/cts.2019.00129</doi>
              <publisherRecordId>95</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Pneumoretroperitoneum, pneumomediastinum, pneumothorax and subcutaneous emphysema after diagnostic colonoscopy</title>
                <authors>
                              <author>
                                <name>Önder  Kavurmacı</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Asuman Akın Türker</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Bülent  Alkan</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Orhan  Üreyen</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Tahsin Tekeli</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Bozyaka Training and Research Hospital, Izmir Turkey</affiliationName><affiliationName affiliationId="2">Department of Gastroenterology, Bozyaka Training and Research Hospital, Izmir Turkey</affiliationName><affiliationName affiliationId="3">Department of General Surgery, Bozyaka Training and Research Hospital, Izmir Turkey</affiliationName></affiliationsList><abstract language="eng">Colonoscopy is a safe procedure and in less than 1% of the patients, colonic perforation may be
seen. Physical examination findings such as pain and distension of the abdomen are well-known
symptoms however, dyspnea and tachypnea are seen in only a small number of cases as a sign of
iatrogenic colon perforation. In this report, we present a 70-year-old female patient with iatrogenic
pneumoperitoneum, pneumomediastinum, subcutaneous emphysema and bilateral pneumothorax after
diagnostic colonoscopy. The patient was successfully treated with endoscopic colon repair and left
tube thoracostomy. When atypical findings are present such as dyspnea and subcutaneous emphysema,
iatrogenic pneumothorax, pneumomediastinum should be kept mind after colonoscopy.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=95</fullTextUrl>
              <keywords><keyword>colonoscopy</keyword><keyword>dyspnea</keyword><keyword>pneumothorax</keyword><keyword>pneumomediastinum</keyword><keyword>subcutaneous emphysema</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2019-12-31</publicationDate>
              <volume>4</volume>
              <issue>3</issue>
              <startPage>150</startPage>
              <endPage>152</endPage>
              <doi>10.26663/cts.2019.00130</doi>
              <publisherRecordId>96</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Novel surgical integration technique in ravitch procedure using an atraumatic o-ring wound retractor: case report</title>
                <authors>
                              <author>
                                <name>Sergio Alberto Sanchez Vergara</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Gerardo Rea Mendoza</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Justo José Lopez Gimenez</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Organismo público descentralizado de hospitales civiles de Guadalajara, Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, México</affiliationName></affiliationsList><abstract language="eng">Modified Ravitch procedure is the hallmark surgical procedure to repair pectus deformities, manual and
auto self-retaining metal retractors are very helpful because they grant and maintain the surgical site
exposure. However, these metal retractors often have sharp tips that are capable of causing soft tissue
flaps damage. In abdominal surgery, using an atraumatic O-ring wound retractor has been associated
with diminution of superficial surgical site complications and post-operative pain reduction due, these
suggested benefits can be reproducible in modified Ravitch procedure. A 20-year-old male patient is
referred to our service for presenting chest discomfort and body image issues. Subsequent work up
revealed a pectus carinatum without associated congenital heart disease. A transverse infra-mammary
skin 8 cm incision was made. We used an atraumatic O-ring wound retractor to expose surgical site
and performed bilateral subperichondrial abnormal costal cartilages resection with sternum wedge
osteotomy. Drains was removed in 24 hours, and the post-surgical hospital stay was 72 hours. In this
case, using an atraumatic O-ring wound retractor improved exposure with shorter incision, facilitated
stable access to the costal cartilage, protecting the skin from injury, and reduced the administration of
intravenous analgesics.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=96</fullTextUrl>
              <keywords><keyword>modified Ravitch procedure</keyword><keyword>pectus</keyword><keyword>auto self-retractor</keyword><keyword>atraumatic O-ring wound retractor</keyword><keyword>surgical retractor</keyword>
                  </keywords>
            </record></records>